Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?

被引：2

作者：

Sharma, Nitin ^{[1
]}

Kulkarni, Giriraj T. ^{[2
]}

Bhatt, Anant Narayan ^{[3
]}

Satija, Saurabh ^{[4
,5
]}

Singh, Lubhan ^{[6
]}

Sharma, Anjana ^{[7
]}

Dua, Kamal ^{[4
]}

Karwasra, Ritu ^{[8
]}

Khan, Asim Ali ^{[8
]}

Ahmad, Nadeem ^{[9
]}

Raza, Khalid ^{[10
]}

机构：

[1] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India

[2] Gokaraju Rangaraju Coll Pharm, Hyderabad, Telangana, India

[3] Def Res & Dev Org, Dept Nucl Med, Inst Nucl Med & Allied Sci, Delhi, India

[4] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW, Australia

[5] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India

[6] Swami Vivekanand Subharti Univ, KharvelSubharti Coll Pharm, Dept Pharmacol, Meerut, Uttar Pradesh, India

[7] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut, UP, India

[8] Govt India, Cent Council Res Unani Med CCRUM, Minist AYUSH, New Delhi, India

[9] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India

[10] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India

来源：

NATURAL PRODUCT COMMUNICATIONS | 2022年 / 17卷 / 09期

关键词：

SARS-CoV-2; herbal medicine; natural product; coronavirus; pneumonia; GLYCYRRHIZIC ACID; BETULINIC ACID; CORONAVIRUS SARS-COV-2; ENTEROVIRUS; 71; IN-VITRO; DERIVATIVES; PHARMACOLOGY; INHIBITORS; HESPERIDIN; LYCORINE;

D O I：

10.1177/1934578X221126303

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works.

引用

页数：10

共 50 条

[31] Coinfection with SARS-CoV-2 and influenza A virus
Kondo, Yuki
Miyazaki, Shinichi
Yamashita, Ryo
Ikeda, Takuya
BMJ CASE REPORTS, 2020, 13 (07)
[32] Immunopathology of SARS-CoV-2 virus infection
Javier Espinosa-Rosales, Francisco
ACTA PEDIATRICA DE MEXICO, 2020, 41 (04): : S42 - S50
[33] Novel Corona Virus (SARS-CoV-2)
Hoenemann, Mario
Luebbert, Christoph
Liebert, Uwe G.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (05) : 336 - 337
[34] A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19)
Huang, Fangfang
Li, Ying
Leung, Elaine Lai-Han
Liu, Xiaohua
Liu, Kaifeng
Wang, Qu
Lan, Yongqi
Li, Xiaoling
Yu, Haibing
Cui, Liao
Luo, Hui
Luo, Lianxiang
PHARMACOLOGICAL RESEARCH, 2020, 158
[35] Performance of ginger constituents against SARS-CoV-2 virus: A therapeutic and theoretical approach
Kadhim, Mustafa M.
Khadom, Anees A.
Abaies, Jawad Kadhim
Kadhum, Wesam R.
Hachim, Safa K.
PARASITE EPIDEMIOLOGY AND CONTROL, 2024, 25
[36] Potential Antiviral Options against SARS-CoV-2 Infection
Ianevski, Aleksandr
Yao, Rouan
Fenstad, Mona Hoysaeter
Biza, Svetlana
Zusinaite, Eva
Reisberg, Tuuli
Lysvand, Hilde
Loseth, Kirsti
Landsem, Veslemoy Malm
Malmring, Janne Fossum
Oksenych, Valentyn
Erlandsen, Sten Even
Aas, Per Arne
Hagen, Lars
Pettersen, Caroline H.
Tenson, Tanel
Afset, Jan Egil
Nordbo, Svein Arne
Bjoras, Magnar
Kainov, Denis E.
VIRUSES-BASEL, 2020, 12 (06):
[37] Pooled testing for SARS-CoV-2, options for efficiency at scale
Reilly, Marie
Chohan, Bhavna
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2021, 99 (10) : 708 - 714
[38] SARS-CoV-2 in perioperative medicine: lessons learnt
Eochagain, Aisling Ni
Hardman, Jonathan G.
Buggy, Donal J.
BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (05) : E187 - E188
[39] Diving and hyperbaric medicine in the SARS-CoV-2 pandemic
Mitchell, Simon J.
DIVING AND HYPERBARIC MEDICINE, 2020, 50 (02) : 90 - 91
[40] Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs
Jones, Les
Bakre, Abhijeet
Naikare, Hemant
Kolhe, Ravindra
Sanchez, Susan
Mosley, Yung-Yi C.
Tripp, Ralph A.
PLOS ONE, 2021, 16 (09):

← 1 2 3 4 5 →